PPARG and type 2 diabetes mellitus: Adipose tissue seasonality has important implications for immunology, obesity and metabolic disease research; for example, PPARG, targeted by thiazolidinediones as a current treatment of type 2 diabetes, was found to be seasonal in adipose tissue (ANOVA, , P=3.75 × 10−9).